Overview
| Metric | Value |
|---|---|
| Date | March 21, 2026 |
| Domain | Oncology — ovarian cancer vs endometriosis |
| Agents | 24 |
| Packets | 1,502 |
| Parse validity | 100% |
| Compression ratio | 10.41x |
| Fidelity score | F = 97.6 |
The Question
Patient 7291, female, age 47. CA-125 at 285 U/mL (8.1x elevation). Complex cystic mass on ultrasound. History of endometriosis. Does she have ovarian cancer or endometriosis?The Deliberation
24 agents — oncologists, pathologists, radiologists, surgeons, patient advocates, clinical guidelines databases — debated across 12 rounds using only AXL packets. Key moments:- Round 3: Oncologist infers malignancy (INF.82) from CA-125 + imaging
- Round 5: Pathologist contradicts (CON.65) citing endometriosis history
- Round 7: Oncologist yields (YLD.55) — changes from malignant to uncertain
- Round 10: Merge (MRG.70) — both viable, biopsy indicated
- Round 12: Prediction convergence at 60% malignancy probability
